UROMODULIN AS A PREDICTOR OF NEPHROPATHY IN ARTERIAL HYPERTENSION IN THE POST-COVID PERIOD
Keywords:
COVID-19, uromodulin, arterial hypertension, nephropathy, type IV collagen, post-COVID syndromeAbstract
Scientific studies conducted worldwide have shown that hypertension is the most common comorbidity in COVID-19, confirming that it is registered in 10-34% of cases. Their combination leads to severe complications not only of COVID-19, but also of hypertension, including kidney damage. The article presents the results of a study of modern approaches to the early diagnosis of nephropathy caused by the above diseases.
References
1. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129-133.
2. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1)
3. Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38(5):781–782.
4. Giyosova NO Basic moments of kidney damage in covid-19 in patients with Comorbid diseases// Tibbiyotda Yangi kun. 2021 No. 6 p. 227-232 (14.0.0.00)
5. Giyosova NO Nurov BB Course and therapy of arterial hypertension in patients with covid-19 // Web of scientist: international scientific research journal. Volume 3, Issue 12, 1142-1149 . Dec., 2022
6. Giyosova NO Uromodulin as an early marker in the diagnosis of chronic kidney disease // Asian journal of Pharmaceutical and biological research. Volume 12. 42-49. May-Aug.2023
7. https://www.interfax.ru/chronicle/novyj-koronavirus-v-kitae.html .
8. Akhmedova N.Sh., Giyosova N.O. Buyrak functional zaҳirasini aniklash - surunkali buyrak kasalliklari erta diagnostics sifatida predictor // Journal of Cardiorespiratory Research. Materials of the II International Scientific and Practical Conference (Samarkand, April 7-8, 2023) Volume II
9. Dzhanashiya P.Kh., Poteshkina N.G., Selivanova G.B. Arterial hypertension. M: Miklosh. 2007. 168 p.
10. Smirnov AV, Hasun M, Kayukov IG, et al. Serum uromodulin as an early biomarker of tubular atrophy and interstitial fibrosis in patients with glomerulopathies. Ter arkh 2018;90(6):41–44. doi:
10.26442/terarkh201890641-47
